Target intelligence / Profile preview

High mobility group box 1 pseudogene 42 (HMGB1P42)

Target
HMGB1P42
Molecular classification
Other (Pseudogene)
01

Overview

High mobility group box 1 pseudogene 42 (HMGB1P42) is a nonfunctional, processed pseudogene related in sequence to the HMGB1 gene, which encodes the high mobility group box 1 protein—a chromatin-associated protein involved in DNA binding, chromatin remodeling, and regulation of transcription in the cell nucleus[3]. Pseudogenes like HMGB1P42 have high sequence similarity to functional parental genes but contain disabling mutations (such as frameshifts or premature stop codons) that prevent the production of a functional protein product[3]. Most pseudogenes are transcriptionally silent, but in certain cases (more typically in other pseudogenes), the RNA transcripts may regulate parental gene expression through mechanisms such as acting as molecular decoys for microRNAs or other RNA-binding proteins[1][2]. There is currently no evidence that HMGB1P42 itself has any such function, involvement in disease, or value as a therapeutic target.

Other names
HMGB1-P42
02

Mechanism of action

None

03

Biological functions

None (pseudogenes do not encode functional protein; some have regulatory RNA roles)
04

Disease associations

None directly for HMGB1P42Broadly, some HMGB-family pseudogenes can influence parental gene expression in cancer and other diseases by acting as competing endogenous RNAs

Beyond the preview

Go deeper on High mobility group box 1 pseudogene 42 (HMGB1P42).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group box 1 pseudogene 42 (HMGB1P42).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call